Stifel Recaps Alto Neuroscience (ANRO) Investor Day, 'risk/reward is favorable', Shares Gain ~7.3%
Tweet Send to a Friend
Stifel analyst Paul Matteis reiterated a Buy rating and $32.00 price target on Alto Neuroscience (NYSE: ANRO).The analyst comments "We ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
